Karin Mengele

599 total citations
24 papers, 456 citations indexed

About

Karin Mengele is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Karin Mengele has authored 24 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Karin Mengele's work include Protease and Inhibitor Mechanisms (10 papers), Peptidase Inhibition and Analysis (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Karin Mengele is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Peptidase Inhibition and Analysis (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Karin Mengele collaborates with scholars based in Germany, Netherlands and Denmark. Karin Mengele's co-authors include Manfred Schmitt, Nadia Harbeck, Fred C.G.J. Sweep, Ute Reuning, Nils Brünner, Rudolf Napieralski, Viktor Magdolen, John A. Foekens, P.M. Schaffer and Karin A. Herrmann and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Karin Mengele

24 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Mengele Germany 13 188 181 172 91 62 24 456
Alexander Barrett United States 12 224 1.2× 268 1.5× 123 0.7× 70 0.8× 35 0.6× 17 615
M L Lamelas Spain 11 200 1.1× 244 1.3× 283 1.6× 53 0.6× 54 0.9× 12 547
Giovanni Roveroni Italy 11 173 0.9× 197 1.1× 195 1.1× 67 0.7× 32 0.5× 18 523
Zsuzsa Rákosy Hungary 15 277 1.5× 259 1.4× 137 0.8× 44 0.5× 26 0.4× 23 511
Shima Uneda Japan 11 264 1.4× 189 1.0× 124 0.7× 50 0.5× 25 0.4× 17 495
Masao Furuhashi Japan 7 479 2.5× 212 1.2× 95 0.6× 60 0.7× 30 0.5× 7 615
Lian‐He Yang China 16 383 2.0× 147 0.8× 107 0.6× 148 1.6× 37 0.6× 41 673
Iker Antón Spain 9 305 1.6× 225 1.2× 214 1.2× 93 1.0× 26 0.4× 15 538
Maurizia Giai Italy 9 281 1.5× 136 0.8× 70 0.4× 103 1.1× 103 1.7× 13 573
Paul Perrotte Canada 7 284 1.5× 216 1.2× 179 1.0× 70 0.8× 21 0.3× 12 552

Countries citing papers authored by Karin Mengele

Since Specialization
Citations

This map shows the geographic impact of Karin Mengele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Mengele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Mengele more than expected).

Fields of papers citing papers by Karin Mengele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Mengele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Mengele. The network helps show where Karin Mengele may publish in the future.

Co-authorship network of co-authors of Karin Mengele

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Mengele. A scholar is included among the top collaborators of Karin Mengele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Mengele. Karin Mengele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludyga, Natalie, Nataša Anastasov, Michael Rosemann, et al.. (2013). Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells. Molecular Cancer Research. 11(4). 381–392. 20 indexed citations
2.
Dorn, Julia, Matthias Kotzsch, Marcus Kremer, et al.. (2013). Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer. Biological Chemistry. 395(1). 95–107. 20 indexed citations
3.
Kolk, Andreas, Karin Mengele, Klaus Mantwill, et al.. (2011). Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients. British Journal of Cancer. 105(12). 1864–1873. 35 indexed citations
4.
Mengele, Karin, Rudolf Napieralski, Viktor Magdolen, et al.. (2010). Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics. 10(7). 947–962. 37 indexed citations
5.
Schmitt, Manfred, Karin Mengele, Rudolf Napieralski, et al.. (2010). Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics. 10(8). 1051–1067. 52 indexed citations
6.
Gluz, Oleg, Karin Mengele, Manfred Schmitt, et al.. (2009). Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy. Journal of Clinical Oncology. 27(36). 6144–6151. 39 indexed citations
7.
Horn, Carsten, et al.. (2009). The effect of antibacterial acting extracorporeal shockwaves on bacterial cell integrity.. PubMed. 15(12). BR364–9. 8 indexed citations
8.
Weirich, Gregor, Karin Mengele, Christina Yfanti, et al.. (2008). Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines. Biological Chemistry. 389(11). 1441–1445. 9 indexed citations
9.
Stemmler, Hans‐Joachim, Karin Mengele, Manfred Schmitt, et al.. (2008). Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Anti-Cancer Drugs. 19(8). 832–836. 63 indexed citations
10.
Schmitt, Manfred, Karin Mengele, Rudolf Napieralski, et al.. (2008). Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects. Breast Care. 3(2). 2–2. 21 indexed citations
11.
12.
Schilling, Daniela, Christine Bayer, Anneke Geurts‐Moespot, et al.. (2007). Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines. BMC Cancer. 7(1). 143–143. 17 indexed citations
13.
Beaufort, Nathalie, Dominique Leduc, Hiroshi Eguchi, et al.. (2007). The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(5). L1263–L1272. 35 indexed citations
14.
15.
Sprague, Lisa, Karin Mengele, Daniela Schilling, et al.. (2006). Effect of Reoxygenation on the Hypoxia-Induced Up-Regulation of Serine Protease Inhibitor PAI-1 in Head and Neck Cancer Cells. Oncology. 71(3-4). 282–291. 12 indexed citations
16.
17.
Mengele, Karin, et al.. (2005). Tumorassoziierte Prognosefaktoren der Plasminogenaktivator-Familie. Hämostaseologie. 25(3). 301–310. 5 indexed citations
18.
Minar, E, et al.. (1984). [Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12].. PubMed. 114(2). 48–53. 5 indexed citations
19.
Mengele, Karin, Josef D. Schwarzmeier, Paul G. Schmidt, & K Moser. (1969). [Clinical aspects and studies of erythrocyte metabolism during poisoning with sodium chlorate].. PubMed. 2(2). 120–5. 3 indexed citations
20.
Irsigler, K & Karin Mengele. (1968). [Glucose utilization and serum lipids in chronic kidney insufficiency].. PubMed. 80(38). 711–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Barrett Breakdown of academic impact, for papers by M L Lamelas Breakdown of academic impact, for papers by Giovanni Roveroni Breakdown of academic impact, for papers by Zsuzsa Rákosy Breakdown of academic impact, for papers by Shima Uneda Breakdown of academic impact, for papers by Masao Furuhashi Breakdown of academic impact, for papers by Lian‐He Yang Breakdown of academic impact, for papers by Iker Antón Breakdown of academic impact, for papers by Maurizia Giai Breakdown of academic impact, for papers by Paul Perrotte
Rankless by CCL
2026